We are able to optimize pricing and access strategy through the close integration of product goals and strategies, with the realities of market-specific evidence requirements, payer goals, and competitive threats.
Our fundamentals as strategy consultants, paired with deep expertise in pricing, access, and evidence planning, uniquely position us to help our clients navigate global P&MA environments. We provide detailed, market-specific insights and P&MA strategies, and link them to broader commercial goals. This mix of P&MA and broader commercial expertise allows us to serve our clients’ market access, clinical, and commercial experts.
We work across all key major and emerging markets, providing strategic support in launch price setting and adjustments, launch sequencing, competitive entry strategy, contracting strategy, and evidence generation strategies, tailored to each market.
Our wide-ranging capabilities, deep expertise, and strategic background allow us to provide best-in-class support for P&MA challenges.
Project Types
Market Access Strategy
U.S. and Global P&MA Landscape Assessments
Global Launch Strategy, Sequencing, and Prioritization
Disruptive Trends Analysis
Framework Development
Indication Sequencing
Portfolio P&MA Strategy and Positioning
Pricing and Reimbursement
Early Pricing Strategy
Launch Pricing
Life Cycle Management Pricing
Innovative Pricing and Contracting Strategy
Contract Modelling
Gross-to-net Forecasting
Price and Revenue Optimization Models
Diligence Support
P&MA Due Diligence
Assumption Pressure Testing
Value and Evidence
Integrated HTA and Payer Evidence Planning
Payer Value Proposition Development
Value Driver Analysis
